Categories AlphaGraphs, Earnings, Health Care
ANGO Earnings: A snapshot of AngioDynamics’ Q2 2024 results
AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported a net loss, on an adjusted basis, for the second quarter of 2024 when its revenue declined. The medical device maker also provided guidance for fiscal 2024.
Net loss, excluding special items, was $0.05 per share in the November quarter, compared to earnings of $0.01 per share in the same period of 2023. On an unadjusted basis, net loss was $29.05 million or $0.72 per share in Q2, compared to a loss of $8.49 million or $0.21 per share in the prior-year quarter.
Second-quarter revenues decreased 7% year-over-year to $79.1 million. The company expects fiscal 2024 revenues to be in the range of $320 million to $325 million.
Commenting on the results, AngioDynamics’ CEO Jim Clemmer said, “Currently, more than 80% of our Med Tech revenue utilizes third-party manufacturing. Fully shifting both Med Device and Med Tech to this model will allow us to more effectively compete in our chosen markets, fundamentally changing our corporate gross margin profile and driving us to profitability in two years.”
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Richtech’s mission is to transform the service industry through collaborative robotic solutions: President
Richtech Robotics Inc. (NASDAQ: RR) is a leading provider of robotic solutions, developing, manufacturing, and deploying novel products needed for automation in the service industry. The company's solutions include delivery,
What to expect when Darden Restaurants reports Q1 results
Darden Restaurants, Inc. (NYSE: DRI) is scheduled to release its first-quarter report on September 19, with analysts forecasting a year-over-year increase in sales and profit. The market will be keeping a
Oracle (ORCL) sees continued strong revenue growth in FY25
Oracle Corporation (NYSE: ORCL) started the new fiscal year on a high note with stronger-than-expected first-quarter results, driving the stock higher soon after the announcement. The tech giant’s earnings and
